Abbie Jemmott

Abbie Jemmott serves as a key procurement professional within the Centers for Disease Control and Prevention, supporting the agency’s mission to safeguard public health through strategic acquisitions of critical medical, diagnostic, and supply chain solutions. She manages complex contracting actions for high-priority public health preparedness initiatives, including vaccine distribution systems, laboratory diagnostics, and emergency medical logistics. Her work directly enables CDC’s capacity to respond to infectious disease outbreaks, monitor environmental health threats, and maintain national readiness through timely access to life-saving technologies and pharmaceuticals. Jemmott maintains longstanding relationships with leading biopharmaceutical and medical distribution entities, including Merck Sharp & Dohme LLC, GlaxoSmithKline LLC, Pfizer Inc., Sanofi Pasteur Inc., and McKesson Specialty Distribution LLC. These partnerships reflect a focus on large-scale, mission-critical procurements involving vaccines, therapeutics, cold-chain logistics, and specialty pharmaceutical distribution. Her contracting approach emphasizes reliability, regulatory compliance, and rapid scalability, aligning with CDC’s need for uninterrupted supply chains during public health emergencies. Her procurement portfolio shows a strong preference for full and open competition, with 100% of awards issued under no set-aside classifications. This indicates a strategic emphasis on leveraging the broadest possible market capability rather than targeted socioeconomic programs, prioritizing scale, technical capacity, and operational readiness over small business set-asides such as 8(a), HUBZone, or SDVOSB. While NAICS data is not available, her contracting patterns strongly align with pharmaceutical manufacturing, medical supply distribution, and public health logistics—domains requiring adherence to FDA regulations, GMP standards, and CDC-specific biosafety protocols. Her expertise lies in acquiring high-complexity medical products and services that support national surveillance, outbreak response, and immunization infrastructure.